Acute effects of salt on blood pressure are mediated by serum osmolality

Journal of Clinical Hypertension

Volumn 20, Issue 10, 2018, Pages 1447-1454

  Kanbay, Mehmet ^a   Aslan, Gamze ^a   Afsar, Baris ^b   Dagel, Tuncay ^a   Siriopol, Dimitrie ^c   Kuwabara, Masanari ^d,e   Incir, Said ^a   Camkiran, Volkan ^a   Rodriguez Iturbe, Bernardo ^f   Lanaspa, Miguel A ^d   Covic, Adrian ^c   Johnson, Richard J ^d  

^a KOÇ UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e TORANOMON HOSPITAL   (Japan)

^f HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

Author keywords

blood pressure; copeptin; plasma osmolarity; salt intake

Indexed keywords

COPEPTIN; SODIUM; SODIUM CHLORIDE; VASOPRESSIN; WATER; CHLORIDE; FLAVORING AGENT; GLYCOPEPTIDE;

ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; FASTING; FEMALE; FLUID INTAKE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; LENTIL; MALE; NORMAL HUMAN; PLASMA OSMOLARITY; PRIORITY JOURNAL; SALT INTAKE; SERUM OSMOLALITY; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; VOLUNTEER; ADMINISTRATION AND DOSAGE; ADVERSE EVENT; BLOOD; BLOOD PRESSURE; BODY MASS; CLINICAL TRIAL; EATING; OSMOLARITY; PHARMACOLOGY; PHYSIOLOGY; POSTPRANDIAL STATE; PROCEDURES; SYSTOLE;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BODY MASS INDEX; CHLORIDES; EATING; FEMALE; FLAVORING AGENTS; GLYCOPEPTIDES; HUMANS; MALE; OSMOLAR CONCENTRATION; POSTPRANDIAL PERIOD; SODIUM; SODIUM CHLORIDE, DIETARY; SYSTOLE;

EID: 85053493793     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.13374     Document Type: Article

References (39)

1. Allen FM, Sherrill JW. The treatment of arterial hypertension. J Metabol Research. 1922;2:429_545.
2. Allen FM. Arterial hypertension. JAMA. 1920;74:652_655.
3. Dahl LK. Possible role of salt intake in the development of essential hypertension. In: Cottier P, Bock K, eds. Essential Hypertension _ an International Symposium. Berlin: Springer; 1960:53_65.
4. MacGregor GA. Sodium is more important than calcium in essential hypertension. Hypertension. 1985;7(4):628_640.
5. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension. 2003;42(6):1093_1099.
6. Graudal N, Jurgens G, Baslund B, Alderman MH. Compared with usual sodium intake, low_ and excessive_sodium diets are associated with increased mortality: a meta_analysis. Am J Hypertens. 2014;27(9):1129_1137.
7. Guyton AC, Coleman TG, Fourcade JC, Navar LG. Physiologic control of arterial pressure. Bull N Y Acad Med. 1969;45(9):811_830.
8. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW Abnormal pressure natriuresis. A cause or a consequence of hypertension? Hypertension. 1990;15(6 Pt 1):547_559.
9. Franco M, Tapia E, Bautista R, et al. Impaired pressure natriuresis resulting in salt_sensitive hypertension is caused by tubulointerstitial immune cell infiltration in the kidney. Am J Physiol Renal Physiol. 2013;304(7):F982_F990.
10. Kurtz TW, DiCarlo SE, Morris RC Jr. Logical issues with the pressure natriuresis theory of chronic hypertension. Am J Hypertens. 2016;29(12):1325_1331.
11. de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int. 2004;66(6):2454_2466.
12. Rakova N, Kitada K, Lerchl K, et al. Increased salt consumption induces body water conservation and decreases fluid intake. J Clin Invest. 2017;127(5):1932_1943.
13. Suckling RJ, He FJ, Markandu ND, MacGregor GA. Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int. 2012;81(4):407_411.
14. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem. 2006;52(1):112_119.
15. Khan SQ, Dhillon OS, O'Brien RJ, et al. C_terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation. 2007;115(16):2103_2110.
16. Buggy J, Hoffman WE, Phillips MI, Fisher AE, Johnson AK. Osmosensitivity of rat third ventricle and interactions with angiotensin. Am J Physiol. 1979;236(1):R75_R82.
17. Dunn FL, Brennan TJ, Nelson AE, Robertson GL. The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest. 1973;52(12):3212_3219.
18. Thompson CJ, Bland J, Burd J, Baylis PH. The osmotic thresholds for thirst and vasopressin release are similar in healthy man. Clin Sci (Lond). 1986;71(6):651_656.
19. McKinley MJ, Denton DA, Leventer M, Penschow J, Weisinger RS, Wright RD. Morphology of the organum vasculosum of the lamina terminalis (OVLT) of the sheep. Brain Res Bull. 1983;11(6):649_657.
20. Kinsman BJ, Nation HN, Stocker SD. Hypothalamic signaling in body fluid homeostasis and hypertension. Curr Hypertens Rep. 2017;19(6):50.
21. Broadwell RD, Brightman MW. Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J Comp Neurol. 1976;166(3):257_283.
22. Frithiof R, Xing T, McKinley MJ, May CN, Ramchandra R. Intracarotid hypertonic sodium chloride differentially modulates sympathetic nerve activity to the heart and kidney. Am J Physiol Regul Integr Comp Physiol. 2014;306(8):R567_R575.
23. Kinsman BJ, Browning KN, Stocker SD. NaCl and osmolarity produce different responses in organum vasculosum of the lamina terminalis neurons, sympathetic nerve activity and blood pressure. J Physiol. 2017;595(18):6187_6201.
24. Toney GM, Stocker SD. Hyperosmotic activation of CNS sympathetic drive: implications for cardiovascular disease. J Physiol. 2010;588(Pt 18):3375_3384.
25. Rodriguez_Iturbe B, Pons H, Johnson RJ. Role of the immune system in hypertension. Physiol Rev. 2017;97(3):1127_1164.
26. Bankir L, Bichet DG, Bouby N. Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension? Am J Physiol Renal Physiol. 2010;299(5):F917_F928.
27. Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiol Rev. 2012;92(4):1813_1864.
28. Fedorova OV, Shapiro JI, Bagrov AY. Endogenous cardiotonic steroids and salt_sensitive hypertension. Biochim Biophys Acta. 2010;1802(12):1230_1236.
29. Song Z, Roncal_Jimenez CA, Lanaspa_Garcia MA, et al. Role of fructose and fructokinase in acute dehydration_induced vasopressin gene expression and secretion in mice. J Neurophysiol. 2017;117(2):646_654.
30. Lanaspa MA, Kuwabara M, Andres_Hernando A, et al. High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. Proc Natl Acad Sci USA. 2018.
31. Enhorning S, Struck J, Wirfalt E, Hedblad B, Morgenthaler NG, Melander O. Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab. 2011;96(7):E1065_E1072.
32. Tenderenda_Banasiuk E, Wasilewska A, Filonowicz R, Jakubowska U, Waszkiewicz_Stojda M. Serum copeptin levels in adolescents with primary hypertension. Pediatr Nephrol. 2014;29(3):423_429.
33. Enhorning S, Bankir L, Bouby N, et al. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmo Diet and Cancer Study cardiovascular cohort. Int J Obes (Lond). 2013;37(4):598_603.
34. Enhorning S, Leosdottir M, Wallstrom P, et al. Relation between human vasopressin 1a gene variance, fat intake, and diabetes. Am J Clin Nutr. 2009;89(1):400_406.
35. Enhorning S, Wang TJ, Nilsson PM, et al. Plasma copeptin and the risk of diabetes mellitus. Circulation. 2010;121(19):2102_2108.
36. Schoen T, Hohmann EM, Van Der Lely S, et al. Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults. J Hypertens. 2015;33(8):1571_1579.
37. Mendes M, Dubourg J, Blanchard A, et al. Copeptin is increased in resistant hypertension. J Hypertens. 2016;34(12):2458_2464.
38. Perucca J, Bichet DG, Bardoux P, Bouby N, Bankir L. Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists. J Am Soc Nephrol. 2008;19(9):1721_1731.
39. Gizowski C, Zaelzer C, Bourque CW. Clock_driven vasopressin neurotransmission mediates anticipatory thirst prior to sleep. Nature. 2016;537(7622):685_688.